10-Q 1 e10-q.txt FORM 10-Q 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2000 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to _______________________ Commission File No. 0-11488 Penford Corporation -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Washington 91-1221360 -------------------------------------------------------------------------------- (State of Incorporation) (I.R.S. Employer Identification No.) 777-108th Avenue N.E., Suite 2390, Bellevue, WA 98004-5193 -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (425) 462-6000 Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of July 5, 2000.
Class Outstanding ----- ----------- Common stock, par value $1.00 7,403,924
2 PENFORD CORPORATION AND SUBSIDIARIES INDEX
Page No. -------- PART I - FINANCIAL INFORMATION Item 1 - Financial Statements Condensed Consolidated Balance Sheets May 31, 2000 and August 31, 1999 3 Condensed Consolidated Statements of Income Three and Nine Months Ended May 31, 2000 and May 31, 1999 4 Condensed Consolidated Statements of Cash Flow Nine Months Ended May 31, 2000 and May 31, 1999 5 Notes to Condensed Consolidated Financial Statements 6-7 Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations 8-10 Item 3 - Quantitative and Qualitative Disclosures About Market Risk 10 PART II - OTHER INFORMATION Item 1 - Legal Proceedings 11 Item 2 - Changes in Securities 11 Item 3 - Defaults Upon Senior Securities 11 Item 4 - Submission of Matters to a Vote of Security Holders 11 Item 5 - Other Information 11 Item 6 - Exhibits and Reports on Form 8-K 11-13 SIGNATURES 14
2 3 PART I - FINANCIAL INFORMATION Item 1 Financial Statements PENFORD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Dollars in thousands)
May 31, 2000 August 31, 1999 ------------ --------------- ASSETS Current assets: Cash and cash equivalents $ 447 $ 15 Trade accounts receivable 17,758 18,418 Inventories: Raw materials and other 3,633 3,423 Work in progress 415 438 Finished goods 7,601 6,260 --------- --------- 11,649 10,121 Prepaid expenses and other 6,796 4,384 --------- --------- Total current assets 36,650 32,938 Net property, plant and equipment 114,903 111,072 Deferred income taxes 12,925 13,849 Restricted cash value of life insurance 12,180 11,896 Other assets 3,206 3,378 --------- --------- Total assets $ 179,864 $ 173,133 ========= ========= LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 11,256 $ 9,655 Accrued liabilities 11,751 9,185 Current portion of long-term debt 2,857 3,277 --------- --------- Total current liabilities 25,864 22,117 Long-term debt 50,729 53,101 Other postretirement benefits 10,746 10,572 Deferred income taxes 20,402 21,769 Other liabilities 6,449 5,876 Shareholders' equity: Common stock 9,341 9,267 Additional paid-in capital 22,208 21,459 Retained earnings 66,310 59,370 Treasury stock (32,185) (30,327) Note receivable from Savings and Stock Ownership Plan -- (71) --------- --------- Total shareholders' equity 65,674 59,698 --------- --------- Total liabilities and shareholders' equity $ 179,864 $ 173,133 ========= =========
See accompanying notes to condensed consolidated financial statements. 3 4 PENFORD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Dollars in thousands except per share data)
Three Months Ended May 31 Nine Months Ended May 31 ----------------------------- ----------------------------- 2000 1999 2000 1999 ----------- ----------- ----------- ----------- Sales $ 39,744 $ 39,226 $ 118,629 $ 115,146 Cost of sales 28,633 29,008 85,248 85,408 ----------- ----------- ----------- ----------- Gross margin 11,111 10,218 33,381 29,738 Operating expenses 4,243 4,811 13,313 13,696 Research and development 1,365 1,423 4,031 3,846 Restructure costs -- 1,559 -- 1,559 ----------- ----------- ----------- ----------- Income from operations 5,503 2,425 16,037 10,637 Interest expense (1,051) (1,343) (3,532) (4,087) ----------- ----------- ----------- ----------- Income before taxes 4,452 1,082 12,505 6,550 Income taxes 1,558 379 4,377 2,293 ----------- ----------- ----------- ----------- Net income $ 2,894 $ 703 $ 8,128 $ 4,257 =========== =========== =========== =========== Weighted average common shares and equivalents outstanding 7,795,053 7,701,498 7,758,400 7,767,554 Earnings per common share: Net income Basic $ 0.39 $ 0.09 $ 1.10 $ 0.58 =========== =========== =========== =========== Diluted $ 0.37 $ 0.09 $ 1.05 $ 0.55 =========== =========== =========== =========== Dividends declared per common share $ 0.06 $ 0.05 $ 0.16 $ 0.15 =========== =========== =========== ===========
See accompanying notes to condensed consolidated financial statements. 4 5 PENFORD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Dollars in thousands)
Nine Months Ended May 31 ------------------------ 2000 1999 -------- --------- Operating Activities: Net income $ 8,128 $ 4,257 Adjustments to reconcile net income to net cash from operations: Depreciation 10,168 9,250 Deferred income taxes (444) (260) Change in operating assets and liabilities: Trade receivables 660 2,168 Inventories (1,528) 4,494 Accounts payable, prepaids and other 2,113 4,610 Net cash used in discontinued operations -- (1,133) -------- -------- Net cash from operating activities 19,097 23,386 Investing Activities: Additions to property, plant and equipment, net (13,938) (13,064) Other 575 475 -------- -------- Net cash used by investing activities (13,363) (12,589) Financing Activities: Proceeds from unsecured line of credit 44,177 26,320 Payments on unsecured line of credit (43,692) (30,671) Proceeds of long-term debt -- 10,000 Payments on long-term debt (3,277) (17,487) Exercise of stock options 466 645 Purchase of treasury stock (1,858) (919) Payment of dividends (1,118) (1,103) -------- -------- Net cash used by financing activities (5,302) (13,215) -------- -------- Net increase (decrease) in cash and equivalents 432 (2,418) Cash and cash equivalents at beginning of period 15 3,200 -------- -------- Cash and cash equivalents at end of period $ 447 $ 782 ======== ========
See accompanying notes to condensed consolidated financial statements. 5 6 PENFORD CORPORATION AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 1. BUSINESS Penford Corporation ("Penford" or the "Company") develops, manufactures and markets specialty carbohydrate-based ingredient systems for various applications, including papermaking, textiles and food products. The Company utilizes its expertise in carbohydrate chemistry to develop functional ingredient formulations using starch as a base for value-added applications in the markets its products are sold. The Company has extensive research and development capabilities, which are used in understanding the complex chemistry of carbohydrate-based materials and their application in a variety of commercial markets. In addition, the Company has specialty processing capabilities for a variety of modified starches, all of which have similar production methods. Penford's core carbohydrate-based specialty starches possess excellent binding and film-forming attributes in both industrial and food applications. 2. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation for the interim periods presented have been included. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Operating results for the three and nine month periods ended May 31, 2000 are not necessarily indicative of the results that may be expected for the year ending August 31, 2000. For further information, refer to the consolidated financial statements and footnotes thereto included in Penford Corporation's annual report on Form 10-K for the fiscal year ended August 31, 1999. Certain prior year amounts have been reclassified to conform with current year presentation, which had no effect on previously reported net income. 6 7 3. EARNINGS PER COMMON SHARE The following table presents the computation of basic and diluted earnings per share under SFAS No. 128 (Dollars in thousands except per share data):
Three Months Ended Nine Months Ended May 31 May 31 -------------------------- -------------------------- 2000 1999 2000 1999 ---------- ---------- ---------- ---------- Net income $ 2,894 $ 703 $ 8,128 $ 4,257 ========== ========== ========== ========== Weighted average common shares outstanding 7,417,229 7,416,605 7,419,943 7,389,852 Net effect of dilutive stock options 377,824 284,893 338,457 377,702 ---------- ---------- ---------- ---------- Weighted average common shares outstanding assuming dilution 7,795,053 7,701,498 7,758,400 7,767,594 ========== ========== ========== ========== Earnings per common share: Net income Basic $ 0.39 $ 0.09 $ 1.10 $ 0.58 ========== ========== ========== ========== Diluted $ 0.37 $ 0.09 $ 1.05 $ 0.55 ========== ========== ========== ==========
Basic earnings per share reflects only the weighted average common shares outstanding. Diluted earnings per share reflects weighted average common shares outstanding and the effect of any dilutive common stock equivalent shares. 7 8 Item 2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS RESULTS OF OPERATIONS Consolidated sales increased to $39.7 million from $39.2 million, or 1.3%, in the third quarter of fiscal 2000 versus the same prior year period. Sales for the first nine months of fiscal 2000 increased to $118.6 million from $115.1 million, or 3.0%, compared to the same prior year period. Sales growth for the quarter and nine-month period is attributed to higher company-wide sales volumes of specialty starches. Lower corn costs, a key pricing component, and pricing pressures on certain paper ingredient products continued to dampen overall sales growth. Industrial sales volumes of specialty products increased approximately 10% in the third quarter and approximately 9% in the first nine months of fiscal 2000 on solid operating performance for industrial ingredients, including paper and textiles. Sales volumes of specialty food starches in the third quarter and first nine months of fiscal 2000 increased 34% and 27%, respectively, over the same periods in the prior year. The continued strong demand for food-grade, starch-based systems for food industry customers resulted in the overall increase in consolidated sales. Gross margin improved to $11.1 million, or 28.0%, in the third quarter, from $10.2 million, or 26.1%, in the corresponding prior year period. The gross margin improvement is the result of higher sales volume and manufacturing efficiency gains across all of the Company's product lines. Cost savings achieved in manufacturing and raw material purchasing for specialty starches for papermaking applications more than offset the related pricing pressures and slightly higher energy costs. Gross margin for the nine months ended May 31, 2000 increased to $33.4 million, or 28.1%, from $29.7 million, or 25.8%, for the same nine-month period in the prior year. The year-to-date improvement is also attributed to the volume increases, efficiency gains and cost savings. Operating expenses in the third quarter of $4.2 million were $568,000 lower compared to the same quarter in the prior year. For the nine months ended May 31, 2000, operating expenses decreased to $13.3 million from $13.7 million. The decreases resulted primarily from lower corporate costs and the effect of the prior year's workforce reduction program. Restructuring costs totaling $1.6 million were charged to continuing operations in the third quarter a year ago in connection with the workforce reduction program. Research and development expenses in the third quarter of $1.4 million were consistent with the same quarter in the prior year. For the nine months ended May 31, 2000, research and development expenses increased 5% compared to the prior year, primarily due to commercialization efforts and alliance activities in specialty ingredient systems. Net interest expense for the third quarter and first nine months of fiscal 2000 was $1.1 million and $3.5 million, respectively, compared to $1.3 million and $4.1 million, 8 9 respectively, in the corresponding periods a year ago. The decreases reflect lower outstanding debt balances. The effective tax rate for the third quarter and first nine months of fiscal 2000 was 35%, the same as in the corresponding periods a year ago. The effective rate for the full fiscal year is expected to be similar. Net income for the third quarter ended May 31, 2000 was $2.9 million, or $0.37 per share, compared to net income of $703,000, or $0.09 per share in the corresponding prior year period. Net income for the nine months ended May 31, 2000 was $8.1 million, or $1.05 per share, compared to $4.3 million, or $0.55 per share, for the same period in the prior year. The quarter and nine-month prior year periods include the $1.6 million restructuring charge ($1.0 million after tax) noted above. All per share amounts above assume dilution. LIQUIDITY AND CAPITAL RESOURCES At May 31, 2000, Penford had working capital of $10.8 million, an unsecured credit agreement of $75.0 million under which there was $34.0 million outstanding, and several uncommitted lines of credit aggregating $10.0 million under which there was $1.0 million outstanding. The Company used operating cash flow through the first nine months of fiscal 2000 primarily to invest in capital expenditures of $13.9 million and to fund financing activities of $5.3 million, including principal debt repayments of $2.8 million. Cash flow from operations for the nine months ended May 31, 2000 was $19.1 million compared to $23.4 million in the corresponding period of the prior year. The decrease in operating cash flow compared to the prior year is due to fluctuations in the components of working capital, primarily due to efforts in the prior year to reduce inventory, offset by higher net income in the current fiscal year. The Company began paying a quarterly cash dividend of $0.05 per share in 1992 and has continued to pay quarterly dividends ever since. On April 3, 2000, the Board of Directors approved an increase in the quarterly cash dividend to $0.06 per share. In November of 1998, the Board of Directors authorized a stock repurchase program for the purchase of up to 500,000 shares of the outstanding stock of the company. The Company repurchased 112,800 shares of its common stock in the first nine months of fiscal 2000 for approximately $1.9 million. From inception of the program through May 31, 2000, the Company has repurchased 253,000 shares of its common stock for $3.8 million. Net additions to property, plant and equipment during the third quarter of $5.4 million were primarily for various improvements at the Company's industrial facility in Cedar Rapids, Iowa and equipment additions and improvements at the Company's food-grade manufacturing facilities. 9 10 FORWARD-LOOKING STATEMENTS This report contains forward-looking statements concerning the anticipated performance and results of the Company. There are a variety of factors which could cause actual events or results to differ materially from those projected in the forward-looking statements, including, without limitation, competition; the possibility of interruption of business activities due to equipment problems, accidents, strikes, weather or other factors; product development risk; changes in raw material prices and/or energy costs; interest rate volatility; changes in general economic conditions or developments with respect to specific industries or customers affecting demand for the Company's products including unfavorable shifts in product mix; unanticipated costs, expenses or third party claims; the risk that results may be affected by construction delays, cost overruns, technical difficulties, nonperformance by contractors or changes in capital improvement project requirements or specifications; or other unforeseen developments in the industries in which the Company operates. Accordingly, there can be no assurance that future activities or results will be as anticipated. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. The Company assumes no obligation to update any forward-looking statements if circumstances or management's estimates or opinions should change. Additional information which could affect the Company's financial results is included in the Company's 1999 Annual Report to Shareholders and its Form 10-K for the fiscal year ended August 31, 1999 on file with the Securities and Exchange Commission. Item 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK MARKET RISK SENSITIVE INSTRUMENTS AND POSITIONS The market risk associated with the Company's market risk sensitive instruments is the potential loss from adverse changes in interest rates and commodities prices. The Company is unaware of any material changes to the market risk disclosures referred to in the Company's Report on Form 10-K for the year ended August 31, 1999. 10 11 PART II - OTHER INFORMATION Item 1 Legal Proceedings A complaint was filed in late November 1999 against Penford in the United States District Court for the District of Idaho, alleging various violations of the federal Clean Air Act, as well as claims for trespass and nuisance by alleged emissions from Penford's Idaho Falls starch processing plant. The subject of the complaint involves alleged excessive starch emissions that occurred in 1996 and 1997, which were previously disclosed by the Company, and certain other alleged violations relating to the plant. The complaint sought civil penalties, together with private damages. By agreement of the parties, the Federal Clean Air Act claims have been dismissed with prejudice. Non-binding mediation for the remaining trespass and nuisance claims is tentatively scheduled for late August. Item 2 Changes in Securities Not applicable Item 3 Defaults Upon Senior Securities Not applicable Item 4 Submission of Matters to a Vote of Security Holders Not applicable Item 5 Other Information Not applicable Item 6 Exhibits and Reports on Form 8-K. (a) Exhibits: (3.1) Restated Articles of Incorporation of Registrant (filed as an Exhibit to Registrant's Form 10-K for fiscal year ended August 31, 1995) (3.2) Articles of Amendment to Restated Articles of Incorporation of Registrant (filed as an exhibit to Registrant's Form 10-K for fiscal year ended August 31, 1997) (3.3) Bylaws of Registrant as amended and restated as of October 20, 1997 (filed as an exhibit to Registrant's Form 10-K for fiscal year ended August 31, 1997) (4.1) Amended and Restated Rights Agreement dated as of April 30, 1997 (filed as an Exhibit to Registrant's Amendment to Registration Statement on Form 8-A/A dated May 5, 1997) (10.1) Senior Note Agreement among Penford Corporation as Borrower and Mutual of Omaha and Affiliates as lenders, dated November 1, 1992 (filed as an Exhibit to Registrant's Form 10-Q for the quarter ended February 28, 1993) 11 12 (10.2) Penford Corporation Supplemental Executive Retirement Plan, dated March 19, 1990 (filed as an Exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1991) (10.3) Penford Corporation Supplemental Survivor Benefit Plan, dated January 15, 1991 (filed as an Exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1991) (10.4) Penford Corporation Deferred Compensation Plan, dated January 15, 1991 (filed as an Exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1991) (10.5) Change of Control Agreements between Penford Corporation and Messrs. Cook and Horn (a representative copy of these agreements is filed as an exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1995) (10.6) Penford Corporation 1993 Non-Employee Director Restricted Stock Plan (filed as an Exhibit to Registrant's Form 10-Q for the quarter ended November 30, 1993) (10.7) Senior Note Agreement dated as of October 1, 1994 among Penford Corporation, Principal Mutual Life Insurance Company and TMG Life Insurance Company (filed as an Exhibit to Registrant's Form 10-Q for the quarter ended February 28, 1995) (10.8) Penford Corporation 1994 Stock Option Plan as amended and restated as of January 21, 1997 (filed on Form S-8 dated March 17, 1997) (10.9) Penford Corporation Stock Option Plan for Non-Employee Directors (filed as an exhibit to the Registrant's Form 10-Q for the quarter ended May 31, 1996) (10.10) Separation Agreement dated as of July 31, 1998 between Registrant and Penwest Pharmaceuticals Co. (filed as an exhibit to Registrant's Form 8-K dated August 31, 1998) (10.11) Services Agreement dated as of July 31, 1998 between Registrant and Penwest Pharmaceuticals Co. (filed as an exhibit to Registrant's Form 8-K dated August 31, 1998) (10.12) Employee Benefits Agreement dated as of July 31, 1998 between Registrant and Penwest Pharmaceuticals Co. (filed as an exhibit to Registrant's Form 8-K dated August 31, 1998) (10.13) Tax Allocation Agreement dated as of July 31, 1998 between Registrant and Penwest Pharmaceuticals Co. (filed as an exhibit to Registrant's Form 8-K dated August 31, 1998) (10.14) Excipient Supply Agreement dated as of July 31, 1998 between Registrant and Penwest Pharmaceuticals Co. (filed as an exhibit to Registrant's Form 8-K dated August 31, 1998) (10.15) Restatement and Exchange Agreement amending the Senior Note Agreement among Penford Corporation as Borrower and Mutual of Omaha and Affiliates as lenders, dated as of August 1, 1998 (filed as an exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1998) 12 13 (10.16) Co., a wholly-owned subsidiary of Registrant, of the Restatement and Exchange Agreement among Registrant and Mutual of Omaha and Affiliates (filed as an exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1998) (10.17) Intercreditor Agreement dated as of August 1, 1998 among the parties to the Credit Agreement dated July 2, 1998 and the parties to the Senior Note Agreements dated as of August 1, 1998 (filed as an exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1998) (10.18) Restatement and Exchange Agreement amending the Senior Note Agreement among Penford Corporation as Borrower, and Principal Mutual Life Insurance Company and TMG Life Insurance Company as lenders, dated as of August 1, 1998 (filed as an exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1998) (10.19) Guaranty Agreement dated as of August 1, 1998 by Penford Products Co., a wholly-owned subsidiary of Registrant, of the Restatement and Exchange Agreement among Registrant, Principal Mutual Life Insurance Company, and TMG Life Insurance Company (filed as an exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1998) (10.20) Credit Agreement dated as of July 2, 1998 among Penford Corporation and Penford Products Co. as borrowers, and certain commercial lending institutions as the lenders, and The Bank of Nova Scotia, as agent for the lenders (filed as an exhibit to Registrant's Form 10-K for the fiscal year ended August 31, 1998) 27 Financial Data Schedule (b) There were no filings on Form 8-K in the quarter ended May 31, 2000. 13 14 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Penford Corporation ----------------------------------- (Registrant) July 12, 2000 /s/ Jeffrey T. Cook ------------- ----------------------------------- Date Jeffrey T. Cook President and Chief Executive Officer (Principal Executive Officer) July 12, 2000 /s/ Keith T. Fujinaga ------------- ----------------------------------- Date Keith T. Fujinaga Corporate Director of Finance (Chief Accounting Officer) 14